)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Shanghai Henlius Biotech (2696) investor relations material
Shanghai Henlius Biotech H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary25 Aug, 2025
Executive summary
Revenue for 1H2025 rose 2.7% YoY to RMB2,819.5 million, driven by drug sales, R&D services, and license income.
Net profit reached RMB390.1 million, with a net margin of 13.8%.
International expansion accelerated, with products approved in nearly 60 countries/regions, benefiting over 850,000 patients globally.
Key products achieved significant regulatory milestones in the EU, US, and other markets, with new licensing and collaboration agreements signed.
Operating cash flow surged to RMB771 million, a 207% YoY increase.
Financial highlights
Gross profit rose 10.5% YoY to RMB2,199.2 million.
R&D expenses increased to RMB995.4 million, representing 20.8% of revenue.
Selling and distribution expenses grew to RMB987.8 million.
Cash and bank balances stood at RMB889.2 million, up 31.4% YoY.
Earnings per share: RMB0.72 (basic and diluted) for the period.
Outlook and guidance
Plans to launch over 10 products overseas in the next 3-5 years, including key biosimilars and innovative drugs.
Revenue and profit from overseas markets expected to grow considerably in H2 2025 and maintain high-speed growth in 2026.
Anticipated approvals for HANSIZHUANG, HLX11, and HLX14 in additional countries.
Multiple NDA/BLA/MAA submissions and approvals expected in 2025H2 and 2026H1 for major products.
Continued expansion of the product pipeline, with several IND applications planned.
Detail HANSIZHUANG's EU commercialization plan
Explain the strategic value of recent pipeline additions
How do Songjiang plants support global product supply?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Shanghai Henlius Biotech earnings date
H2 202523 Mar, 2026
Next Shanghai Henlius Biotech earnings date
H2 202523 Mar, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Shanghai Henlius Biotech Inc is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of biologic drugs, particularly biosimilars and monoclonal antibody therapies. The company’s product portfolio addresses a range of therapeutic areas, including oncology, autoimmune diseases, and infectious diseases. Henlius operates advanced manufacturing facilities and research centers, employing innovative biotechnology to support its drug development pipeline and expand access to biologic treatments. The company is headquartered in Shanghai, China, and its shares are listed on the HKEX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage